Role of monocytes in atherogenesis

Physiological Reviews

Volumn 83, Issue 4, 2003, Pages 1069-1112

  Østerud, Bjarne ^a   Bjørklid, Eirik ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; CD14 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; GROWTH FACTOR; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE; PROTEOGLYCAN; THROMBOCYTE ACTIVATING FACTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; CYTOKINE PRODUCTION; DNA POLYMORPHISM; ENDOCYTOSIS; ENDOTHELIUM; EXTRACELLULAR MATRIX; FOAM CELL; GLYCATION; HUMAN; INFLAMMATION; INTIMA; LEUKOCYTE FUNCTION; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; TRANSGENIC MOUSE; UPREGULATION;

EID: 0141639811     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00005.2003     Document Type: Review

References (586)

1. Abraham R, Choudhury A, Basu SK, Bal V, and Rath S. Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors. J Immunol 158: 4029-4035, 1997.
2. Abramovitz M, Wong E, Cox ME, Richardson CD, Li C, and Vickers PJ. 5-Lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem 215: 105-111, 1993.
3. Adachi H, Tsujimoto M, Arai H, and Inoue K. Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem 272: 31217-31220, 1997.
4. Aggarwal BB and Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7: 93-124, 1996.
5. 4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol 22: 443-449, 2002.
6. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, and Milos PM. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19: 1518-1525, 1999.
7. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12: 59-63, 2000.
8. Akira S, Hirano T, Taga T, and Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4: 2860-2867, 1990.
9. Allen S, Khan S, Al-Mohanna F, Batten P, and Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest 101: 1064-1075, 1998.
10. Ambrosio G, Oriente A, Napoli C, Palumbo G, Chiariello P, Marone G, Condorelli M, Chiariello M, and Triggiani M. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest 93: 2408-2416, 1994.
11. Annema A, Sluiter W, and van Furth R. Effect of interleukin 1, macrophage colony-stimulating factor, and factor increasing monocytopoiesis on the production of leukocytes in mice. Exp Hematol 20: 69-74, 1992.
12. Anthonsen MW, Stengel D, Hourton D, Ninio E, and Johansen B. Mildly oxidized LDL induces expression of group IIa secretory phospholipase A (2) in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 20: 1276-1282, 2000.
13. Apostolopoulos J, Davenport P, and Tipping PG. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vosc Biol 16: 1007-1012, 1996.
14. Arbustini E, Grasso M, Diegoli M, Pucci A, Bramerio M, Ardissino D, Angoli L, de Servi S, Bramucci E, Mussini A, Minzoni A, Vigano M, and Specchia G. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical, and biochemical study. Am J Cardiol 68: 36B-50B, 1991.
15. Arend WP, Joslin FG, and Massoni RJ. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134: 3868-3875, 1985.
16. Arias-Negrete S, Keller K, and Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 208: 582-589, 1995.
17. Arnaout MA. Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 114: 145-180, 1990.
18. Asea A, Kraeft SK, Kurt-Jones EA, Stevenson MA, Chen LB, Finberg RW, Koo GC, and Calderwood SK. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6: 435-442, 2000.
19. Atkinson JB, Harlan CW, Harlan GC, and Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 25: 154-159, 1994.
20. Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, Coffman TM, and FitzGerald GA. Cardiovascular responses to the isoprostanes iPF (2alpha) -III and iPE (2)-III are mediated via the thromboxane A (2) receptor in vivo. Circulation 101: 2833-2840, 2000.
21. Auer JW, Berent R, Weber T, and Eber B. Immunopathogenesis of atherosclerosis. Circulation 105: E64, 2002.
22. Aviram M. Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol Med Today 5: 381-386, 1999.
23. Aviram M and Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann NY Acad Sci 957: 146-161, 2002.
24. Aviram M, Kent UM, and Hollenberg PF. Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein. Atherosclerosis 143: 253-260, 1999.
25. Bacon CM, Cho SS, and O'Shea JJ. Signal transduction by interleukin-12 and interleukin-2. A comparison and contrast. Ann NY Acad Sci 795: 41-59, 1996.
26. Badimon L, Badimon JJ, Chesebro J-H, and Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 70: 111-118, 1993.
27. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 250: 91-104, 2001.
28. 2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J Biol Chem 271: 32381-32384, 1996.
29. 2. Annu Rev Pharmacol Toxicol 39: 175-189, 1999.
30. 2 by phosphatidylinositol bisphosphate levels. J Immunol 164: 5398-5402, 2000.
31. Baiter MS, Toews GB, and Peters-Golden M. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages. J Immunol 142: 602-608, 1989.
32. Banchereau J, Briere F, Galizzi JP, Miossec P, and Rousset F. Human interleukin 4. J Lipid Mediat Cell Signal 9: 43-53, 1994.
33. Bardot O, Aldridge TC, Latruffe N, and Green S. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 192: 37-45, 1993.
34. Barks JL, McQuillan JJ, and Iademarco MF. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J Immunol 159: 4532-4538, 1997.
35. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W, Rubben A, Mukhtar H, and Merk HF. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 56: 1105-1110, 1998.
36. Barry OP and FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 82: 794-800, 1999.
37. Barry OP, Pratico D, Savani RC, and FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102: 136-144, 1998.
38. Bataille R, Jourdan M, Zhang XG, and Klein B. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 84: 2008-2011, 1989.
39. Bazan HE, Tao Y, and Bazan NG. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc Natl Acad Sci USA 90: 8678-8682, 1993.
40. Belch JJ. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 5: 440-446, 1994.
41. Belkner J, Wiesner R, Rathman J, Barnett J, Sigal E, and Kuhn H. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem 213: 251-261, 1993.
42. Bellavite P. The superoxide-forming enzymatic system of phagocytes. Free Radic Biol Med 4: 225-261, 1988.
43. Benveniste J. PAF-acether, an ether phospho-lipid with biological activity. Prog Clin Biol Res 282: 73-85, 1988.
44. Benz DJ, Mol M, Ezaki M, Mori-Ito N, Zelan I, Miyanohara A, Friedmann T, Parthasarathy S, Steinberg D, and Witztum JL. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem 270: 5191-5197, 1995.
45. Berkhout TA, Sarau HM, Moores K, White JR, Elshourbagy N, Appelbaum E, Reape R J, Brawner M, Makwana J, Foley JJ, Schmidt DB, Imburgia C, McNulty D, Matthews J, O'Donnell K, O'Shannessy D, Scott M, Groot PHE, and Macphee C. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem 272: 16404-16413, 1997.
46. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, and Lusis AJ. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496, 1995.
47. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, and Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85: 1260-1266, 1990.
48. Bigby TD and Holtzman MJ. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects. J Immunol 138: 1546-1550, 1987.
49. Billiau A, Heremans H, Vermeire K, and Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann NY Acad Sci 856: 22-32, 1998.
50. Bilora F, Dei Rossi C, Girolami B, Casonato A, Zanon E, Bertomoro A, and Girolami A. Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. Clin Appl Thromb Hemost 5: 232-235, 1999.
51. 2 generation in mouse bone marrow-derived mast cells. J Biol Chem 271: 25936-25944, 1996.
52. Bober LA, Grace MJ, Pugliese-Sivo C, Rojas-Triana A, Sullivan LM, and Narula SK. The effects of colony stimulating factors on human monocyte cell function. Int J Immunopharmacol 17: 385-392, 1995.
53. Bocan TM, Rosebury WS, Mueller SB, Kuchera S, Welch K, Daugherty A, and Cornicelli JA. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis 136: 203-216, 1998.
54. Boerboom LE, Olinger GN, Almassi GH, and Skrinska VA. Both dietary fish-oil supplementation and aspirin fail to inhibit atherosclerosis in long-term vein bypass grafts in moderately hypercholesterotemic nonhuman primates. Circulation 96: 968-974, 1997.
55. Bogdan C and Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 685: 713-739, 1993.
56. Boisvert WA, Curtiss LK, and Terkeltaub RA. Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21: 129-137, 2000.
57. Bonavida B, Mencia-Huerta JM, and Braquet P. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor. Int Arch Allergy Appl Immunol 88: 157-160, 1989.
58. Bonavida B, Mencia-Huerta JM, and Braquet P. Effects of platelet-activating factor on peripheral blood monocytes: induction and printing for TNF secretion. J Lipid Mediat 2: S65-S76, 1990.
59. Bonta IL, Adolfs MJ, and Fieren MW. Cyclic AMP levels and their regulation by prostaglandins in peritoneal macrophages of rats and humans. Int J Immunopharmacol 6: 547-555, 1984.
60. 2. Nature 390: 622-625, 1997.
61. Borgeat P, Hamberg M, and Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. J Biol Chem 251: 7816-7820, 1976.
62. Boring L, Gosling J, Cleary M, and Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897, 1998.
63. Bradding P, Redington AE, Djukanovic R, Conrad DJ, and Holgate ST. 15-Lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med 151: 1201-1204, 1995.
64. Braissant O, Fonfelle F, Scotto C, Dauca M, and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
65. Brand K, Banka CL, Mackman N, Terkeltaub RA, Fan ST, and Curtiss LK, Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 14: 790-797, 1994.
66. Brandwein SR. Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. J Biol Chem 261: 8624-8632, 1986.
67. Bray MA, McKearn-Smith C, Metz-Virca G, Bodmer JL, and Virca GD. Stimulated release of neutral proteinases elastase and cathepsin G from inflammatory rat polymorphonuclear leukocytes. Inflammation 11: 23-37, 1987.
68. Breimo ES and Osterud B. Characterization of platelets in patients with inherited large platelet syndrome. In: Vasular Protection, Molecular Mechanisms, Novel Therapeutic Principles and Clinical Application, edited by Rubanyi G, Dzau V, and Cooke J. New York: Taylor & Francis, 2002, p. 359-367.
69. Breyer MD, Jacobson HR, and Breyer RM. Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol 7: 8-17, 1996.
70. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, and Modlin RL. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-736, 1999.
71. Brohee D and Higuet N. In vitro stimulation of peripheral blood mononuclear cells by phytohaemagglutinin A induces CD45RA expression on monocytes. Cytobios 71: 105-111, 1992.
72. Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
73. Buchanan MR, Butt RW, Magas Z, van Ryn J, Hirsh J, and Nazir DJ. Endothelial cells produce a lipoxygenase derived chemo-repellent which influences platelet/endothelial cell interactions-effect of aspirin and salicylate. Thromb Haemost 53: 306-311, 1985.
74. Buchanan MR, Haas TA, Lagarde M, and Guichardant M. 13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem 260: 16056-16059, 1985.
75. Burgess AW and Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56: 947-958, 1980.
76. Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, Marnett LJ, Morrow JD, Fazio S, and Linton MF. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 105: 1816-1823, 2002.
77. Callaghan MM, Lovis RM, Rammohan C, Lu Y, and Pope RM. Autocrine regulation of collagenase gene expression by TNF-alpha in U937 cells. J Leukoc Biol 59: 125-132, 1996.
78. Cavaillon JM. Cytokines and macrophages. Biomed Pharmacother 48: 445-453, 1994.
79. Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ, and Cohen RA. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol 20: 1724-1728, 2000.
80. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, and Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91: 8767-8771, 1994.
81. Cerilli J, Brasile L, and Karmody A. Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann Surg 202: 329-334, 1985.
82. Cerletti C, Evangelista V, and de Gaetano G. P-selectin-beta 2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 82: 787-793, 1999.
83. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, and Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82: 513-520, 1993.
84. Chait A and Wight TN. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11: 457-463, 2000.
85. Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog Horm Res 50: 317-332, 1995.
86. Chan BM, Elices MJ, Murphy E, and Hemler ME. Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J Biol Chem 267: 8366-8370, 1992.
87. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis 112: 69-76, 1995.
88. Chen YM, Wu KD, Tsai TJ, and Hsieh BS. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells. J Mol Cell Cardiol 31: 773-783, 1999.
89. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Maid Z, Fruchart JC, Chapman J, Najib J, and Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273: 25573-25580, 1998.
90. Chisolm GM III, Hazen SL, Fox PL, and Cathcart MK. The oxidation of lipoproteins by monocytes-macrophages. Biochemical and biological mechanisms. J Biol Chem 274: 25959-25962, 1999.
91. Christen S, Thomas SR, Garner B, and Stocker R. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway. J Clin Invest 93: 2149-2158, 1994.
92. Chuluyan HE, Schall TJ, Yoshimura T, and Issekutz AC. IL-1 activation of endothelium supports VLA-4 (CD49d/CD29)-mediated monocyte transendothelial migration to C5a, MIP-1 alpha, RANTES, and PAF but inhibits migration to MCP-1: a regulatory role for endothelium-derived MCP-1. J Leukoc Biol 58: 71-79, 1995.
93. Clinton SK, Fleet JC, Loppnow H, Salomon RN, Clark BD, Cannon JG, Shaw AR, Dinarello CA, and Libby P. Interleukin-1 gene expression in rabbit vascular tissue in vivo. Am J Pathol 138: 1005-1014, 1991.
94. Colten H, Cole F, Sackstein R, and Auerbach H. Tissue and Specific Regulation of Complement Biosynthesis in Mononuclear Phagocytes. Dordrecht, Germany: Martinus Nijhoff Publishers, 1985.
95. Colville-Nash PR, Qureshi SS, Willis D, and Willoughby DA. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161: 978-984, 1998.
96. Conner EM and Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 12: 274-277, 1996.
97. Conrad DJ, Kuhn H, Mulkins M, Highland E, and Sigal E. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci USA 89: 217-221, 1992.
98. Cornhill JF and Roach MR. Quantitative method for the evaluation of atherosclerotic lesions. Atherosclerosis 20: 131-136, 1974.
99. Cornicelli JA, Butteiger D, Rateri DL, Welch K, and Daugherty A. Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages. J Lipid Res 41: 376-383, 2000.
100. Cornicelli JA and Trivedi BK. 15-Lipoxygenase and its inhibition: a novel therapeutic target for vascular disease. Curr Pharm Des 5: 11-20, 1999.
101. Cornicelli JA, Welch K, Auerbach B, Feinmark SJ, and Daugherty A. Mouse peritoneal macrophages contain abundant omega-6 lipoxygenase activity that is independent of interleukin-4. Arterioscler Thromb Vasc Biol 16: 1488-1494, 1996.
102. Creemers EE, Cleutjens JP, Smits JF, and Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89: 201-210, 2001.
103. 4. Int J Biochem Cell Biol 30: 173-178, 1998.
104. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, and Kelly CJ. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 168: 2795-2802, 2002.
105. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, and Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87: 5134-5138, 1990.
106. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, and Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation 103: 2277-2282, 2001.
107. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, and Funk CD. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 103: 1597-1604, 1999.
108. Danesh J, Collins R, Appleby P, and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279: 1477-1482, 1998.
109. Danesh J, Collins R, and Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 350: 430-436, 1997.
110. Dawson TC, Kuziel WA, Osahar TA, and Maeda N. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143: 205-211, 1999.
111. De Gaetano G, Cerletti C, and Evangelista V. Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis 29: 41-49, 1999.
112. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, and Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274: 32048-32054, 1999.
113. De Martin R, Hoeth M, Hofer-Warbinek R, and Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20: E83-E88, 2000.
114. De Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, and Bult H. Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 19: 2524-2534, 1999.
115. Dentan C, Lesnik P, Chapman MJ, and Ninio E. Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis. Eur J Biochem 236: 48-55, 1996.
116. 4 pathway to inflammation control. Nature 384: 39-43, 1996.
117. Devlin CM, Kuriakose G, Hirsch E, and Tabas I. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. Proc Natl Acad Sci USA 99: 6280-6285, 2002.
118. De Winther MP, Gijbels MJ, van Dijk KW, van Gorp PJ, Suzuki H, Kodama T, Frants RR, Havekes LM, and Hofker MH. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis 144: 315-321, 1999.
119. Dhaliwal BS and Steinbrecher UP. Scavenger receptors and oxidized low density lipoproteins. Clin Chim Acta 286: 191-205, 1999.
120. Diamond P, McGinty A, Sugrue D, Brady HR, and Godson C. Regulation of leukocyte trafficking by lipoxins. Clin Chem Lab Med 37: 293-297, 1999.
121. Diaz B and Lopez-Berestein G. A distinct element involved in lipopolysaccharide activation of the tumor necrosis factor-alpha promoter in monocytes. J Interferon Cytokine Res 20: 741-748, 2000.
122. Diaz MN, Frei B, Vita JA, and Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408-416, 1997.
123. DiChiara MR, Kiely JM, Gimbrone MA Jr, Lee ME, Perrella MA, and Topper JN. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J Exp Med 192: 695-704, 2000.
124. Dickfeld T, Lengyel E, May AE, Massberg S, Brand K, Page S, Thielen C, Langenbrink K, and Gawaz M. Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis. Cardiovasc Res 49: 189-199, 2001.
125. Dietert RR and Golemboski KA. Avian macrophage metabolism. Poult Sci 77: 990-997, 1998.
126. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 44: 153-205, 1989.
127. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA Jr, and O'Connor JV. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433-1450, 1986.
128. Dindzans VJ, MacPhee PJ, Fung LS, Leibowitz JL, and Levy GA. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo. J Immunol 135: 4189-4197, 1985.
129. Djellas Y, Antonakis K, and Le Breton GC. A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins. Proc Natl Acad Sci USA 95: 10944-10948, 1998.
130. Dogne JM, de Leval X, Delarge J, David JL, and Masereel B. New trends in thromboxane and prostacyclin modulators. Curr Med Chem 7: 609-628, 2000.
131. Dong ZM, Brown AA, and Wagner DD. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101: 2290-2295, 2000.
132. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, and Wagner DD. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102: 145-152, 1998.
133. Duguid J. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bacteriol 58: 207-212, 1946.
134. Eilertsen KE and Østerud B. The central role of thromboxane and platelet activating factor receptors in ex vivo regulation of endotoxin-induced monocyte tissue factor activity in human whole blood. J Endotoxin Res 8: 285-293, 2002.
135. Elhage R, Mater A, Pieraggi MT, Thiers JC, Arnal JF, and Bayard F. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation 97: 242-244, 1998.
136. Eliassen LT, Rekdal O, Svendsen JS, and Østerud B. TNF 41-62 and TNF 78-96 have distinct effects on LPS-induced tissue factor activity and the production of cytokines in human blood cells. Thromb Haemost 83: 598-604, 2000.
137. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, and Lobb RR. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584, 1990.
138. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, and Woody JN. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36: 1681-1690, 1993.
139. Elstad MR, La Pine TR, Cowley FS, McEver RP, McIntyre TM, Prescott SM, and Zimmerman GA. P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 155: 2109-2122, 1995.
140. Engstad CS, Lia K, Rekdal O, Olsen JO, and Østerud B. A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leukoc Biol 58: 575-581, 1995.
141. Engstad CS, Laud T, and Østerud B. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets. Thromb Haemost 81: 139-145, 1999.
142. Eriksson EE, Xie X, Werr J, Thoren P, and Lindbom L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 15: 1149-1157, 2001.
143. Ernofsson M and Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 83: 307-320, 1996.
144. Essner R, Rhoades K, McBride WH, Morton DL, and Economou JS. Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes. J Clin Lab Immunol 32: 161-166, 1990.
145. Esterbauer H, Dieber-Rotheneder M, Striegl G, and Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53: 314S-321S, 1991.
146. Falcone DJ, McCaffrey TA, and Vergillo JA. Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis. J Biol Chem 266: 22726-22732, 1991.
147. Fan J, Unoki H, Iwasa S, and Watanabe T. Role of endothelin-1 in atherosclerosis. Ann NY Acad Sci 902: 84-93, 2000.
148. Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM, and Albini A. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 18: 111-120, 2000.
149. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, and Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056, 2000.
150. Ferrante JV, Huang ZH, Nandoskar M, Hii CS, Robinson BS, Rathjen DA, Poulos A, Morris CP, and Ferrante A. Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid. Inhibition of tumor necrosis factor production. J Clin Invest 99: 1445-1452, 1997.
151. Filep JG, Delalandre A, Payette Y, and Foldes-Filep E. Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 96: 295-301, 1997.
152. 4 receptor. J Exp Med 180: 253-260, 1994.
153. 4 on neutrophil activation. Ann NY Acad Sci 714: 64-74, 1994.
154. Folcik VA, Aamir R, and Cathcart MK. Cytokine modulation of LDL oxidation by activated human monocytes. Arterioscler Thromb Vasc Biol 17: 1954-1961, 1997.
155. Forman BM, Chen J, and Evans RM. Hypolipidemic drugs, poly-unsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.
156. 2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812, 1995.
157. 2. Biochem J 308: 815-822, 1995.
158. Fourcin M, Chevalier S, Lebrun JJ, Kelly P, Pouplard A, Wijdenes J, and Gascan H. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J Immunol 24: 277-280, 1994.
159. Frostegard J, Huang YH, Ronnelid J, and Schafer-Elinder L. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism. Arterioscler Thromb Vasc Biol 17: 963-968, 1997.
160. Furie B, Furie BC, and Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 86: 214-221, 2001.
161. Furstenberger G, Hagedorn H, Jacobi T, Besemfelder E, Stephan M, Lehmann WD, and Marks F. Characterization of an 8-lipoxygenase activity induced by the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate in mouse skin in vivo. J Biol Chem 266: 15738-15745, 1991.
162. Fuster V and Griggs TR. Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis. Prog Hemost Thromb 8: 159-183, 1986.
163. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, and Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75: 181-189, 1994.
164. Galis ZS, Sukhova GK, Lark MW, and Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503, 1994.
165. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF, and Cosman D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 255: 1434-1437, 1992.
166. Gearing KL, Gottlicher M, Teboul M, Widmark E, and Gustafsson JA. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc Natl Acad Sci USA 90: 1440-1444, 1993.
167. Geng YJ, Holm J, Nygren S, Bruzelius M, Stemme S, and Hansson GK. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. Arterioscler Thromb Vasc Biol 15: 1995-2002, 1995.
168. Geng YJ and Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 147: 251-266, 1995.
169. Geng YJ, Wu Q, Muszynski M, Hansson GK, and Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 16: 19-27, 1996.
170. George J, Mulkins M, Shaish A, Casey S, Schatzman R, Sigal E, and Harats D. Interleukin (IL)-4 deficiency does not influence fatty streak formation in C57BL/6 mice. Atherosclerosis 153: 403-411, 2000.
171. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic J, Wick G, and Harats D. Enhanced fatty streak formation in C57BU/6J mice by immunization with heat shock protein-65. Arterioscler Thromb Vasc Biol 19: 505-510, 1999.
172. George SJ. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis. Curr Opin Lipidol 9: 413-423, 1998.
173. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723, 1999.
174. 2. J Biol Chem 265: 8658-8664, 1990.
175. Glover S, de Carvalho MS, Bayburt T, Jonas M, Chi E, Leslie CC, and Gelb MH. Translocation of the 85-kDa phospholipase A2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 270: 15359-15367, 1995.
176. 4 to receptors on human polymorphonuclear leukocytes. J Immunol 129: 1600-1604, 1982.
177. Gomez-Munoz A, Martens JS, and Steinbrecher UP. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol 20: 135-143, 2000.
178. Goodwin JS, Gualde N, Aldigier J, Rigaud M, and Vanderhoek, JY. Modulation of Fc gamma receptors on I cells and monocytes by 15 hydroperoxyeicosatetranoic acid. Prostaglandins Leukotrienes Med 13: 109-112, 1984.
179. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, and Charo IF. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103: 773-778, 1999.
180. Gough PJ, Greaves DR, Suzuki H, Hakkinen T, Hiltunen MO, Turunen M, Herttuala SY, Kodama T, and Gordon S. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler Thromb Vasc Biol 19: 461-471, 1999.
181. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, and Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239: 497-500, 1988.
182. Grage-Griebenow E, Lorenzen D, Fetting R, Flad HD, and Ernst M. Phenotypical and functional characterization of Fc gamma receptor I (CD64)-negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur J Immunol 23: 3126-3135, 1993.
183. Grainger DJ, Mosedale DE, and Metcalfe JC. TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev 11: 133-145, 2000.
184. Griendling KK and Alexander RW. Oxidative stress and cardiovascular disease. Circulation 96: 3264-3265, 1997.
185. Griswold DE and Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 16: 181-206, 1996.
186. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, and Gottlieb A-B. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367-6371, 1989.
187. Guan JL and Hynes RO. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1. Cell 60: 53-61, 1990.
188. Guha M and Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
189. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, and Schindler C. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99: 2752-2761, 1997.
190. Haas H, Falcone FH, Schramm G, Haisch K, Gibbs BF, Klaucke J, Poppelmann M, Becker WM, Gabius HJ, and Schlaak M. Dietary lectins can induce in vitro release of and IL-4 and IL-13 from human basophils. Eur J Immunol 29: 918-927, 1999.
191. Haas TA, Bastida E, Nakamura K, Hullin F, Admirall L, and Buchanan MR, Binding of 13-HODE and 5-, 12- and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim Biophys Acta 961: 153-159, 1988.
192. Hajjar KA, Gavish D, Breslow JL, and Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339: 303-305, 1989.
193. Halvorsen H, Olsen JO, and Østerud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. J Leukoc Biol 54: 275-282, 1993.
194. Hamanaka R, Kohno K, Seguchi T, Okamura K, Morimoto A, Ono M, Ogata J, and Kuwano M. Induction of low density lipoprotein receptor and a transcription factor SP-1 by tumor necrosis factor in human microvascular endothelial cells. J Biol Chem 267: 13160-13165, 1992.
195. Hamberg M and Hamberg G. On the mechanism of the oxygenation of arachidonic acid by human platelet lipoxygenase. Biochem Biophys Res Commun 95: 1090-1097, 1980.
196. Hamberg M and Samuelsson B. On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J Biol Chem 242: 5329-5335, 1967.
197. Hamilton JA, Myers D, Jessup W, Cochrane F, Byrne R, Whitty G, and Moss S. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 19: 98-105, 1999.
198. Hammerschmidt DE, Kotasek D, McCarthy T, Huh PW, Freyburger G, and Vercellotti GM. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte printing by platelet activating factor. J Lab Clin Med 112: 254-263, 1988.
199. Han J, Hajjar DP, Febbraio M, and Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 272: 21654-21659, 1997.
200. Han J and Nicholson AC. Lipoproteins modulate expression of the macrophage scavenger receptor. Am J Pathol 152: 1647-1654, 1998.
201. Hansson A, Serhan CN, Haeggstrom J, Ingelman-Sundberg M, and Samuelsson B. Activation of protein kinase C by lipoxin A and other eicosanoids. Intracellular action of oxygenation products of arachidonic acid. Biochem Biophys Res Commun 134: 1215-1222, 1986.
202. Hart PH, Bonder CS, Balogh J, Dickensheets HL, Donnelly RP, and Finlay-Jones JJ. Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol 66: 575-578, 1999.
203. Hartwell DW and Wagner DD. New discoveries with mice mutant in endothelial and platelet selectins. Thromb Haemost 82: 850-857, 1999.
204. Haskill S, Johnson C, Eierman D, Becker S, and Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 140: 1690-1694, 1988.
205. Hatada EN, Krappmann D, and Scheidereit C. NF-kappaB and the innate immune response. Curt Opin Immunol 12: 52-58, 2000.
206. Hawrylowicz CM, Howells GL, and Feldmann M. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med 174: 785-790, 1991.
207. Hayek T, Oiknine J, Brook JG, and Aviram M. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice. Biochem Biophys Res Commun 205: 1072-1078, 1994.
208. Hayes AL, Smith C, Foxwell BM, and Brennan FM. CD45-induced tumor necrosis factor alpha production in monocytes is phosphatidylinositol 3-kinase-dependent and nuclear factor-kappaB-independent. J Biol Chem 274: 33455-33461, 1999.
209. Heldin CH and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999.
210. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, and Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391: 591-594, 1998.
211. 2 alpha on the rabbit lung in vivo. Prostaglandins 53: 69-82, 1997.
212. Hiltunen T, Luoma J, Nikkari T, and Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 92: 3297-3303, 1995.
213. 2. J Biol Chem 274: 5163-5169, 1999.
214. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, and Kishimoto T. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797-1801, 1988.
215. Hjelms E, Nordestgaard BG, Stender S, and Kjeldsen K. A surgical model to study in vivo efflux of cholesterol from porcine aorta. Evidence for cholesteryl ester transfer through the aortic wall. Atherosclerosis 77: 239-249, 1989.
216. Hofnagel O, Luechtenborg B, Plenz G, and Robenek H. Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells. Arterioscler Thromb Vasc Biol 22: 710-711, 2002.
217. Honda HM, Leitinger N, Frankel M, Goldhaber JI, Natarajan R, Nadler JL, Weiss JN, and Berliner JA. Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites. Arterioscler Thromb Vasc Biol 19: 680-686, 1999.
218. 4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA 81: 2191-2193, 1984.
219. Huang Y, Jaffa A, Koskinen S, Takei A, and Lopes-Virella MF. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol 19: 1600-1607, 1999.
220. Huang Y, Mironova M, and Lopes-Virella MF. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 19: 2640-2647, 1999.
221. Huang ZH, Bates EJ, Ferrante JV, Hii CS, Poulos A, Robinson BS, and Ferrante A. Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives. Circ Res 80: 149-158, 1997.
222. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R, and Schmitz G. C (-260)-→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220, 1999.
223. Hubbard AK and Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28: 1379-1386, 2000.
224. Huber SA, Sakkinen P, Conze D, Hardin N, and Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 2364-2367, 1999.
225. Huo Y and Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 173: 35-43, 2001.
226. 2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler Thromb Vasc Biol 17: 300-309, 1997.
227. Idriss HT and Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech 50: 184-195, 2000.
228. Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, and Cybulsky MI. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85: 199-207, 1999.
229. Inaba T, Shimano H, Gotoda T, Harada K, Shimada M, Ohsuga J, Watanabe Y, Kawamura M, Yazaki Y, and Yamada N. Expression of platelet-derived growth factor beta receptor on human monocyte-derived macrophages and effects of platelet-derived growth factor BB dimer on the cellular function. J Biol Chem 268: 24353-24360, 1993.
230. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, and Yancopoulus GD. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 69: 1121-1132, 1992.
231. Issemann I, Prince RA, Tugwood JD, and Green S. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11: 37-47, 1993.
232. Ito D, Murata M, Tanahashi N, Sato H, Sonoda A, Saito I, Watanabe K, and Fukuuchi Y. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31: 2661-2664, 2000.
233. Iuliano L, Colavita AR, Leo R, Pratico D, and Violi F. Oxygen free radicals and platelet activation, Free Radic Biol Med 22: 999-1006, 1997.
234. 2. Arterioscler Thromb Vasc Biol 19: 1284-1290, 1999.
235. Jarrold BB, Bacon WL, and Velleman SG. Expression and localization of the proteoglycan decorin during the progression of cholesterol induced atherosclerosis in Japanese quail: implications for interaction with collagen type I and lipoproteins. Atherosclerosis 146: 299-308, 1999.
236. Jiang C, Ting AT, and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86, 1998.
237. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, and Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257: 88-91, 1992.
238. Johnston B, Burns AR, Suematsu M, Issekutz TB, Woodman RC, and Kubes P. Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J Clin Invest 103: 1269-1276, 1999.
239. Jonasson L, Bondjers G, and Hansson GK. Lipoprotein lipase in atherosclerosis: its presence in smooth muscle cells and absence from macrophages. J Lipid Res 28: 437-445, 1987.
240. Jong MC, Hendriks WL, van Vark LC, Dahlmans VE, Groener JE, and Havekes LM. Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis. Artetioscler Thromb Vasc Biol 20: 144-151, 2000.
241. Jorgensen L, Haerem JW, and Moe N. Platelet thrombosis and non-traumatic intimal injury in mouse aorta. Thromb Diath Haemorrh 29: 470-489, 1973.
242. Jovinge S, Ares MP, Kallin B, and Nilsson J. Human monocytes/macrophages release TNF-alpha in response to OX-LDL. Arterioscler Thromb Vasc Biol 16: 1573-1579, 1996.
243. Juliano RL and Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 120: 577-585, 1993.
244. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, and Schroder JM. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176: 587-592, 1992.
245. Kansas GS. Structure and function of L-selectin. APMIS 100: 287-293, 1992.
246. Kaplan M and Aviram M. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37: 777-787, 1999.
247. Kaplan M and Aviram M. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake. Arterioscler Thromb Vasc Biol 21: 386-393, 2001.
248. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, and Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81: 2492-2495, 1993.
249. Kato M, Tokuyama K, Morikawa A, Kuroume T, and Barnes PJ. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. Eur J Pharmacol 232: 7-12, 1993.
250. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, and Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83-85, 1988.
251. Khoo JC, Miller E, McLoughlin P, and Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 8: 348-358, 1988.
252. Khoo JC, Miller E, Pio F, Steinberg D, and Witztum JL. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb 12: 1258-1266, 1992.
253. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, and Berliner JA. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb 14: 427-433, 1994.
254. King VL, Szilvassy SJ, and Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor -/- mice. Arterioscler Thromb Vasc Biol 22: 456-461, 2002.
255. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, and LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535, 2000.
256. Kirsch CM, Sigal E, Djokic TD, Graf PD, and Nadel JA. An in vivo chemotaxis assay in the dog trachea: evidence for chemotactic activity of 8, 15-diHETE. J Appl Physiol 64: 1792-1795, 1988.
257. Kishimoto T, Akira S, Narazaki M, and Taga T. Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254, 1995.
258. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, and Evans RM. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994.
259. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, and Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774, 1992.
260. Kliewer SA and Willson TM. The nuclear receptor PPARgamma: bigger than fat. Curr Opin Genet Dev 8: 576-581, 1998.
261. Klinger MH, Wilhelm D, Bubel S, Sticherling M, Schroder JM, and Kuhnel W. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage. Int Arch Allergy Immunol 107: 541-546, 1995.
262. Klouche M, May AE, Hemmes M, Messner M, Kanse SM, Preissner KT, and Bhakdi S. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler Thromb Vasc Biol 19: 784-793, 1999.
263. Knowles JW and Maeda N. Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 2336-2345, 2000.
264. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, Marz W, Pepys MB, and Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation 100: 2326-2331, 1999.
265. Koike J, Nagata K, Kudo S, Tsuji T, and Irimura T. Density-dependent induction of TNF-alpha release from human monocytes by immobilized P-selectin. FEBS Lett 477: 84-88, 2000.
266. Kol A, Bourcier T, Lichtman AH, and Libby P. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103: 571-577, 1999.
267. Kol A, Lichtman AH, Finberg RW, Libby P, and Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 164: 13-17, 2000.
268. Kol A, Sukhova GK, Lichtman AH, and Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98: 300-307, 1998.
269. Kowala MC, Recce R, Beyer S, Gu C, and Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-I/JE. Atherosclerosis 149: 323-330, 2000.
270. Krakauer T. Human interleukin 1. Crit Rev Immunol 6: 213-244, 1986.
271. 2. Biochim Biophys Acta 959: 269-279, 1988.
272. 4 to a receptor on human polymorphonuclear leukocytes. J Exp Med 157: 628-641, 1983.
273. Krieg P, Kinzig A, Heidt M, Marks F, and Furstenberger G. CDNA cloning of a 8-lipoxygenase and a novel epidermis-type lipoxygenase from phorbol ester-treated mouse skin. Biochim Biophys Acta 1391: 7-12, 1998.
274. Kubes P, Ibbotson G, Russell J, Wallace JL, and Granger DN. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol Gastrointest Liver Physiol 259: G300-G305, 1990.
275. Kume N and Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol 12: 419-423, 2001.
276. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Viksman MY, and Kaplan AP. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 149: 636-642, 1992.
277. Langer C, Huang Y, Cullen P, Wiesenhutter B, Mahley RW, Assmann G, and von Eckardstein A. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages. J Mol Med 78: 217-227, 2000.
278. Le JM, Weinstein D, Gubler U, and Vilcek J. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol 138: 2137-2142, 1987.
279. Lee E, Grodzinsky AJ, Libby P, Clinton SK, Lark MW, and Lee RT. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler Thromb Vasc Biol 15: 2284-2289, 1995.
280. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese JD, Spur BW, Robinson DR, Corey EJ, Lewis RA, and Austen KF. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312: 1217-1224, 1985.
281. Lee TS, Yen HC, Pan CC, and Chau LY. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 734-742, 1999.
282. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, and Park JE. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21: 2004-2010, 2001.
283. Lefer DJ and Granger DN. Monocyte rolling in early atherogenesis: vital role in lesion development. Circ Res 84: 1353-1355, 1999.
284. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, and Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-3410, 1997.
285. Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, and Bhakdi S. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104: 914-920, 2001.
286. Leitinger N, Blazek I, and Sinzinger H. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets. Thromb Res 86: 337-342, 1997.
287. Leitinger N, Watson AD, Faull KF, Fogelman AM, and Berliner JA. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist. Adv Exp Med Biol 433: 379-382, 1997.
288. 2 in atherosclerosis. 2. Potential involvement of biologically active oxidized phospholipids. Arterioscler Thromb Vasc Biol 19: 1291-1298, 1999.
289. Lemberger T, Desvergne B, and Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12: 335-363, 1996.
290. Leonard EJ and Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11: 97-101, 1990.
291. Lessner SM, Prado HL, Waller EK, and Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol 160: 2145-2155, 2002.
292. Leus FR, Wittekoek ME, Prins J, Kastelein JJ, and Voorbij HA. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 149: 371-377, 2000.
293. Levy BD, Romano M, Chapman HA, Reilly JJ, Drazen J, and Serhan CN. Human alveolar macrophages have 15-lipoxygenase and generate 15 (S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest 92: 1572-1579, 1993.
294. Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32: 733-742, 1996.
295. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, and Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531, 2000.
296. 2 in activated human monocytes. Regulation of superoxide anion production and low density lipoprotein oxidation. J Biol Chem 272: 2404-2411, 1997.
297. Li W, Yuan XM, and Brunk UT. OxLDI-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic Res 29: 389-398, 1998.
298. Liao F, Andalibi A, Lusis AJ, and Fogelman AM. Genetic control of the inflammatory response induced by oxidized lipids. Am J Cardiol 75: 65B-66B, 1995.
299. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, and Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 94: 877-884, 1994.
300. Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, and Muller WA. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182: 1337-1343, 1995.
301. Libby P and Galis ZS. Cytokines regulate genes involved in atherogenesis. Ann NY Acad Sci 748: 158-170, 1995.
302. Libby P, Sukhova G, Lee RT, and Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25: S9-S12, 1995.
303. 2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278, 1993.
304. Lindmark E, Tenno T, and Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 20: 2322-2328, 2000.
305. Lipsky PE. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop 28: 8-12, 1999.
306. Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T, and Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 267: 16763-16766, 1992.
307. Lobb RR and Hemler ME. The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 94: 1722-1728, 1994.
308. Locksley RM, Killeen N, and Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501, 2001.
309. Loppnow H, Werdan K, Reuter G, and Flad HD. The interleukin-1 and interleukin-1 converting enzyme families in the cardiovascular system. Eur Cytokine Network 9: 675-680, 1998.
310. Loppnow H, Westphal E, Buchhorn R, Wessel A, and Werdan K. Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 16 Suppl 1: 3-9, 2001.
311. Lund T and Østerud B. Fibrinogen increases lipopolysaccharide-induced tumor necrosis factor-alpha and interleukin-8 release, and enhances tissue factor activity in monocytes in a modified whole blood system. Blood Coagul Fibrinolysis 12: 667-675, 2001.
312. Mach F. The role of chemokines in atherosclerosis. Curr Atheroscler Rep 3: 243-251, 2001.
313. Mach F, Schonbeck U, Sukhova GK, Atkinson E, and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394: 200-203, 1998.
314. Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, and Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94: 1931-1936, 1997.
315. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183: 137-146, 1996.
316. Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, Kalina Z, and Herman ZS. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. Int J Clin Pharmacol Ther 36: 345-349, 1998.
317. Malinauskas RA, Herrmann RA, and Truskey GA. The distribution of intimal white blood cells in the normal rabbit aorta. Atherosclerosis 115: 147-163, 1995.
318. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, and Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res 85: 17-24, 1999.
319. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, and Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19: 611-616, 1999.
320. Mallat Z, Nakamura T, Ohan J, Leseche G, Tedgui A, Maclouf J, and Murphy RC. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J Clin Invest 103: 421-427, 1999.
321. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, and Evans RM. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
322. Manka D, Collins R, Ley K, Beaudet A, and Sarembock I. Absence of P-selectin, but not ICAM-1, attenuates neointimal growth after injury in apolipoprotein-E-deficient mice. Circulation 103: 1000-1005, 2001.
323. Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 82: 165-174, 1999.
324. Mantovani A. The interplay between primary and secondary cytokines. Cytokines involved in the regulation of monocyte recruitment. Drugs 54: 15-23, 1997.
325. 2 enzymes in human monocyte eicosanoid formation. Adv Exp Med Biol 469: 215-219, 1999.
326. 2 does not alter leukotriene formation. J Biol Chem 272: 759-765, 1997.
327. Martens JS, Lougheed M, Gomez-Munoz A, and Steinbrecher UP. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein. J Biol Chem 274: 10903-10910, 1999.
328. Marx N, Schonbeck U, Lazar MA, Libby P, and Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 83: 1097-1103, 1998.
329. Marx N, Sukhova G, Murphy C, Libby P, and Plutzky J. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol 153: 17-23, 1998.
330. Matsumura T, Sakai M, Matsuda K, Furukawa N, Kaneko K, and Shichiri M. Cis-acting DNA elements of mouse granulocyte/macrophage colony-stimulating factor gene responsive to oxidized low density lipoprotein. J Biol Chem 274: 37665-37672, 1999.
331. Mayr M, Kiechl S, Willeit J, Wick G, and Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102: 833-839, 2000.
332. McEver RP. Selectins: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemost 65: 223-228, 1991.
333. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, and Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72: 1307S-1315S, 2000.
334. 4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 83: 2204-2208, 1986.
335. McNally AK, Chisolm GMD, Morel DW, and Cathcart MK. Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J Immunol 145: 254-259, 1990.
336. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, and Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 88: 601-607, 1994.
337. Mehrabian M, Allayee H, Wong J, Shih W, Wang XP, Shaposhnik Z, Funk CD, and Lusis AJ. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res 91: 120-126, 2002.
338. 2 in human atherosclerotic plaques. Atherosclerosis 118: 173-181, 1995.
339. Methia N, Andre P, Denis C, Economopoulos M, Subbarao S, and Wagner DD. Delayed fatty streak formation in von Willebrand factor-deficient mice (Abstract). Circulation 94 Suppl 1: 450a, 1999.
340. Methia N, Andre P, Denis CV, Economopoulos M, and Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 98: 1424-1428, 2001.
341. Miles SA, Rezai AR, Salazar-Gonzalez JF, Vander Meyden M, Stevens RH, Logan DM, Mitsuyasu RT, Taga T, Hirano T, Kishimoto T, and Martinez-Mozar D. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87: 4068-4072, 1990.
342. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, and McEver RP. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 118: 445-456, 1992.
343. Morel DW, Hessler JR, and Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24: 1070-1076, 1983,
344. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, and Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908, 1995.
345. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990.
346. Mortensen RF, Osmand AP, Lint TF, and Gewurz H. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. J Immunol 117: 774-781, 1976.
347. Mueller HW, Purdon AD, Smith JB, and Wykle RL. 1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. Lipids 18: 814-819, 1983.
348. Muller E, Dagenais P, Alami N, and Rola-Pleszczynski M. Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody. Proc Natl Acad Sci USA 90: 5818-5822, 1993.
349. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol 57: 523-528, 1995.
350. Munder M, Mallo M, Eichmann K, and Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 187: 2103-2108, 1998.
351. Murakami M, Kudo I, and Inoue K. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. FEBS Lett 294: 247-251, 1991.
352. 2. J Lipid Mediat Cell Signal 12: 119-130, 1995.
353. Murohara T, Scalia R, and Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78: 780-789, 1996.
354. Musso T, Deaglio S, Franco L, Calosso L, Badolato R, Garbarino G, Dianzani U, and Malavasi F. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. J Leukoc Biol 69: 605-612, 2001.
355. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, and Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100: 550-557, 1997.
356. Nagase H and Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 274: 21491-21494, 1999.
357. Nagy L, Tontonoz P, Alvarez JG, Chen H, and Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240, 1998.
358. Nakano T, Raines EW, Abraham JA, Klagsbrun M, and Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 91: 1069-1073, 1994.
359. Nakashima Y, Raines EW, Plump AS, Breslow JL, and Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 18: 842-851, 1998.
360. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita S, and Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19: 1333-1339, 1999.
361. Naldini A, Sower L, Bocci V, Meyers B, and Carney DH. Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation. J Cell Physiol 177: 76-84, 1998.
362. 2+ signaling pathways display functional and mechanistic diversity. Biochemistry 40: 3089-3100, 2001.
363. Namiki M, Kawashima S, Yamashita T, Ozaki M, Hirase T, Ishida T, Inoue N, Hirata K, Matsukawa A, Morishita R, Kaneda Y, and Yokoyama M. Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia. Arterioscler Thromb Vasc Biol 22: 115-120, 2002.
364. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, and Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100: 2680-2690, 1997.
365. Narumiya S, Sugimoto Y, and Ushikuhi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
366. Nauck M, Roth M, Tamm M, Eickelberg O, Wieland H, Stulz P, and Perruchoud AP. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 16: 398-406, 1997.
367. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, and Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16: 831-842, 1996.
368. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, Reddy ST, Sevanian A, Fonarow GC, and Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein. Steps 2 and 3. J Lipid Res 41: 1495-1508, 2000.
369. Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, and Stern D. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163: 1363-1375, 1986.
370. Nelken NA, Coughlin SR, Gordon D, and Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88: 1121-1127, 1991.
371. Newman PJ. The biology of PECAM-1. J Clin Invest 99: 3-8, 1997.
372. Nielsen LB. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis 123: 1-15, 1996.
373. Nithipatikom K, DiCamelli RF, Kohler S, Gumina RJ, Falck JR, Campbell WB, and Gross GJ. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Anal Biochem 292: 115-124, 2001.
374. O'Connor D, Mihelic E, and Coleman M. Sterochemical course of the auto-oxidative cyclization of lipid hydroperoxides to prostaglandin like bicyclo peroxides. J Am Chem Soc 106: 3577-3584, 1984.
375. O'Neill GP and Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330: 156-160, 1993.
376. Osnes LT, Foss KB, Joo GB, Okkenhaug C, Westvik AB, Ovstebo R, and Kierulf P. Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alpha (TNF-alpha) in human monocytes. Thromb Haemost 76: 970-976, 1996.
377. Osnes LT, Haug KB, Joo GB, Westvik AB, Ovstebo R, and Kierulf P. Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood. Thromb Haemost 83: 868-873, 2000.
378. 2, cyclooxygenases, and lipoxygenases in cultured human umbilical vascular endothelial and smooth muscle cells and in biopsies from umbilical arteries and veins. J Vasc Res 35: 150-155, 1998.
379. Østerud B. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: requirement of platelets and granulocytes. J Leukoc Biol 51: 462-465, 1992.
380. Østerud B. The high responder phenomenon: enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 6: 119-125, 1995.
381. Østerud B. Tissue factor expression in monocytes: in vitro compared to ex vivo. Thromb Haemost 84: 521-522, 2000.
382. Østerud B, Bogwald J, Lindahl U, and Seljelid R. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett 127: 154-160, 1981.
383. Østerud B, Elvevoll EO, Brox J, and Olsen JO. Cellular activation responses in blood in relation to lipid pattern: healthy men and women in families with myocardial infarction or cancer. Blood Coagul Fibrinolysis 13: 399-405, 2002.
384. Østerud B, Lindahl U, and Seljelid R. Macrophages produce blood coagulation factors. FEBS Lett 120: 41-43, 1980.
385. 2. Blood Coagul Fibrinolysis 3: 309-313, 1992.
386. Ouellet S, Muller E, and Rola-Pleszczynski M. IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes. J Immunol 152: 5092-5099, 1994.
387. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, and Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14: 605-616, 1994.
388. Palkama T. Induction of interleukin-1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line. Immunology 74: 432-438, 1991.
389. Palkama T, Matikainen S, and Hurme M. Tyrosine kinase activity is involved in the protein kinase C induced expression of interleukin-1 beta gene in monocytic cells. FEBS Lett 319: 100-104, 1993.
390. Pan ZK. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes. Biochim Biophys Acta 1443: 90-98, 1998.
391. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, and Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92: 471-478, 1993.
392. Park SK, Yang WS, Lee SK, Ahn H, Park JS, Hwang O, and Lee JD. TGF-beta (1) down-regulates inflammatory cytokine-induced VCAM-1 expression in cultured human glomerular endothelial cells. Nephrol Dial Transplant 15: 596-604, 2000.
393. Parthasarathy S, Wieland E, and Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 86: 1046-1050, 1989.
394. Patel SS, Thiagarajan R, Willerson JT, and Yeh ET. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation 97: 75-81, 1998.
395. Pawlowski NA, Abraham E, Hamill A, and Scott WA. The cyclooxygenase and lipoxygenase activities of platelet-depleted human monocytes. J Allergy Clin Immunol 74: 324-330, 1984.
396. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, and Scott WA. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med 158: 393-412, 1983.
397. Penn MS, Saidel GM, and Chisolm GM. Relative significance of endothelium and internal elastic lamina in regulating the entry of macromolecules into arteries in vivo. Circ Res 74: 74-82, 1994.
398. Pepinsky B, Hession C, Chen LL, Moy P, Burkly L, Jakubowski A, Chow EP, Benjamin C, Chi-Rosso G, Luhowskyj S, and Lobb R. Structure/function studies on vascular cell adhesion molecule-1. J Biol Chem 267: 17820-17826, 1992.
399. 2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. Prostaglandins Leukotrienes Essent Fatty Acids 61: 65-82, 1999.
400. Pernerstorfer T, Stohlawetz P, Hollenstein U, Dzirlo L, Eichler HG, Kapiotis S, Jilma B, and Speiser W. Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen. Arterioscler Thromb Vasc Biol 19: 2517-2523, 1999.
401. Pernow J and Wang QD. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 33: 518-526, 1997.
402. Peters-Golden M. Cell biology of the 5-lipoxygenase pathway. Am J Respir Crit Care Med 157: S227-S248, 1998.
403. 2 to the nuclear envelope elicits topographically localized phospholipid hydrolysis. Biochem J 318: 797-803, 1996.
404. Petersen F, Bock L, Flad HD, and Brandt E. Platelet factor 4-induced neutrophil-endothelial cell interaction: involvement of mechanisms and functional consequences different from those elicited by interleukin-8. Blood 94: 4020-4028, 1999.
405. Petit L, Lesnik P, Dachet C, Moreau M, and Chapman MJ. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: relationship to tissue factor induction by cholesterol and oxidized LDL. Arterioscler Thromb Vasc Biol 19: 309-315, 1999.
406. Pfister SL, Schmitz JM, Willerson JT, and Campbell WB. Characterization of arachidonic acid metabolism in Watanabe heritable hyperlipidemic (WHHL) and New Zealand white (NZW) rabbit aortas. Prostaglandins 36: 515-532, 1988.
407. Philip R and Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323: 86-89, 1986.
408. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, Berliner JA, and Fyfe AI. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 19: 2847-2853, 1999.
409. Podrez EA, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP, Cohen PA, Frazier WA, Hoff HF, and Hazen SL. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 105: 1095-1108, 2000.
410. 4: a role for mediation of interleukin 1. Atherosclerosis 113: 11-18, 1995.
411. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AE, and Wells TN. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 270: 19495-19500, 1995.
412. Pratico D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, and FitzGerald GA. Localization of distinct F2-isoprostanes in human atherosclerotic lesions. J Clin Invest 100: 2028-2034, 1997.
413. Prieto J, Eklund A, and Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 156: 191-211, 1994.
414. Pugin J, Ulevitch RJ, and Tobias PS. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 178: 2193-2200, 1993.
415. 2 in regulating arachidonic acid release in macrophages. J Biol Chem 273: 8203-8211, 1998.
416. Quinn MT, Parthasarathy S, Fong LG, and Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84: 2995-2998, 1987.
417. Quinn MT, Parthasarathy S, and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85: 2805-2809, 1988.
418. Rachmilewitz J and Tykocinski ML. Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood 92: 223-229, 1998.
419. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, and Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254-257, 1990.
420. Rajavashisth TB, Yamada H, and Mishra NK. Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-kappa B. Arterioscler Thromb Vasc Biol 15: 1591-1598, 1995.
421. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, and Ley K. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 84: 1237-1244, 1999.
422. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, and Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 93: 14833-14838, 1996.
423. Rankin SM, Parthasarathy S, and Steinberg D. Evidence for a dominant role of lipoxygenase (s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 32: 449-456, 1991.
424. Reale M, Barbacane RC, DiGioacchino M, Felaco M, Croce A, Ferro FM, Lotti TM, and Conti P. Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. Immunol Lett 76: 7-14, 2001.
425. Reape TJ and Groot PH. Chemokines and atherosclerosis. Atherosclerosis 147: 213-225, 1999.
426. Reape TJ, Rayner K, Manning CD, Gee AN, Barnette MS, Burnand KG, and Groot PH. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am J Pathol 154: 365-374, 1999.
427. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, Lukens J, Bluestone J, and Getz GS. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1011-1016, 2001.
428. Reckless J, Rubin EM, Verstuyft JB, Metcalfe JC, and Grainger DJ. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions. Circulation 99: 2310-2316, 1999.
429. 2 that mediates prostaglandin production in mast cells. J Biol Chem 272: 13591-13596, 1997.
430. 4 with a transient increase in cytosolic calcium. Cell Immunol 147: 438-445, 1993.
431. Reid GK, Kargman S, Vickers PJ, Mancini JA, Leveille C, Ethier D, Miller DK, Gillard JW, Dixon RA, and Evans JF. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265: 19818-19823, 1990.
432. Ricote M, Huang J, Fajas L, Li A, Welch J, Najib J, Witztum JL, Auwerx J, Palinski W, and Glass CK. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 95: 7614-7619, 1998.
433. Ricote M, Huang JT, Welch JS, and Glass CK. The peroxisome proliferator-activated receptor (PPARgamma) as a regulator of monocyte/macrophage function. J Leukoc Biol 66: 733-739, 1999.
434. Ridker PM and Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Invest Med 46: 391-395, 1998.
435. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, and Hla T. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for posttranscriptional regulation. J Biol Chem 269: 11769-11775, 1994.
436. Roach MR, Fletcher J, and Cornhill JF. The effect of the duration of cholesterol feeding on the development of sudanophilic lesions in the rabbit aorta. Atherosclerosis 25: 1-11, 1976.
437. Rola-Pleszczynski M, Thivierge M, Ouellet S, Dagenais P, Parent JL, and Stankova J. Cytokines and eicosanoids regulate PAF receptor gene expression. Adv Prostaglandin Thromboxane Leukotriene Res 23: 287-292, 1995.
438. 2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273: 28560-28563, 1998.
439. Rosen ED and Spiegelman BM. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache. J Clin Invest 106: 629-631, 2000.
440. Rosenfeld ME. Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex. Arterioscler Thromb Vasc Biol 22: 361-363, 2002.
441. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126, 1999.
442. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, and Dahinden CA. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176: 1489-1495, 1992.
443. Rothe G, Gabriel H, Kovacs E, Klucken J, Stohr J, Kindermann W, and Schmitz G. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 16: 1437-1447, 1996.
444. Saitoh K, Mori T, Kasai H, Nagayama T, Tsuchiya A, and Ohbayashi S. Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I. Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits. Nippon Yakurigaku Zasshi 106: 41-50, 1995.
445. Sakaguchi H, Takeya M, Suzuki H, Hakamata H, Kodama T, Horiuchi S, Gordon S, van der Laan LJ, Kraal G, Ishibashi S, Kitamura N, and Takahashi K. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest 78: 423-434, 1998.
446. Sakai M, Biwa T, Matsumura T, Takemura T, Matsuda H, Anami Y, Sasahara T, Kobori S, and Shichiri M. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol 19: 1726-1733, 1999.
447. Samuelsson B. The discovery of the leukotrienes. Am J Respir Crit Care Med 161: S2-S6, 2000.
448. Sander HJ, Slot JW, Bouma BN, Bolhuis PA, Pepper DS, and Sixma JJ. Immunocytochemical localization of fibrinogen, platelet factor 4, and beta thromboglobulin in thin frozen sections of human blood platelets. J Clin Invest 72: 1277-1287, 1983.
449. Sanz MJ, Johnston B, Issekutz A, and Kubes P. Endothelin-1 causes P-selectin-dependent leukocyte rolling and adhesion within rat mesenteric microvessels. Am J Physiol Heart Circ Physiol 277: H1823-H1830, 1999.
450. Sartipy P, Johansen B, Gasvik K, and Hurt-Camejo E. Molecular basis for the association of group IIA phospholipase A (2) and decorin in human atherosclerotic lesions. Circ Res 86: 707-714, 2000.
451. Schall TJ, Bacon K, Toy KJ, and Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347: 669-671, 1990.
452. 2 expression in human aortic tissue in dependence on the degree of atherosclerosis. Atherosclerosis 144: 73-78, 1999.
453. 2 to the nuclear envelope and endoplasmic reticilum. J Biol Chem 270: 30749-30754, 1995.
454. Schonbeck U, Sukhova GK, Graber P, Coulter S, and Libby P. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. Am J Pathol 155: 1281-1291, 1999.
455. Schonherr E and Hausser HJ. Extracellular matrix and cytokines: a functional unit. Dev Immunol 7: 89-101, 2000.
456. Schoonjans K, Staels B, and Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37: 907-925, 1996.
457. Schreyer SA, Peschon JJ, and LeBoeaf RC. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 271: 26174-26178, 1996.
458. Schreyer SA, Vick CM, and LeBoeuf RC. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 277: 12364-12368, 2002.
459. Schumann RR, Rietschel ET, and Loppnow H. The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol (Berl) 183: 279-297, 1994.
460. Schwartz CJ, Sprague EA, Kelley JL, Valente AJ, and Suenram CA. Aortic intimal monocyte recruitment in the normo and hypercholesterolemic baboon (Papio cynocephalus). An ultrastructural study: implications in atherogenesis. Virchows Arch A Pathol Anat Histopathol 405: 175-191, 1985.
461. Schwartz SM. The intima: a new soil. Circ Res 85: 877-879, 1999.
462. Schwenke DC and St Clair RW. Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white Carneau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Arterioscler Thromb 13: 1368-1381, 1993.
463. Seeds MC and Bass DA. Regulation and metabolism of arachidonic acid. Clin Rev Allergy Immunol 17: 5-26, 1999.
464. Sempowski GD, Derdak S, and Phipps RP. Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 167: 290-296, 1996.
465. Sendobry SM, Cornicelli JA, Welch K, Bocan T, Tait B, Trivedi BK, Colbry N, Dyer RD, Feinmark SJ, and Daugherty A. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br J Pharmacol 120: 1199-1206, 1997.
466. Senis YA, Richardson M, Tinlin S, Maurice DH, and Giles AR. Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo. Br J Haematol 93: 195-203, 1996.
467. Serhan CN, Hamberg M, and Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA 81: 5335-5339, 1984.
468. Setty BN, Berger M, and Stuart MJ. 13-Hydroxyoctadecadienoic acid (13-HODE) stimulates prostacyclin production by endothelial cells. Biochem Biophys Res Commun 146: 502-509, 1987.
469. Shak S, Perez HD, and Goldstein IM. A novel dioxygenation product of arachidonic acid possesses potent chemotactic activity for human polymorphonuclear leukocytes. J Biol Chem 258: 14948-14953, 1983.
470. Shapiro SD, Campbell EJ, Senior RM, and Welgus HG. Proteinases secreted by human mononuclear phagocytes. J Rheumatol Suppl 27: 95-98, 1991.
471. Shattock RJ, Rizzardi GP, Hayes P, and Griffin GE. Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway. J Infect Dis 174: 54-62, 1996.
472. Shen J, Herderick E, Cornhill JF, Zsigmond E, Kim HS, Kuhn H, Guevara NV, and Chan L. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98: 2201-2208, 1996.
473. Shen RF and Tai HH. Thromboxanes: synthase and receptors. J Biomed Sci 5: 153-172, 1998.
474. Shi W, Haberland ME, Jien ML, Shih DM, and Lusis AJ. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102: 75-81, 2000.
475. Shih PT, Brennan ML, Vora DK, Territo MC, Strahl D, Elices MJ, Lusis AJ, and Berliner JA. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 84: 345-351, 1999.
476. Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, and Yamaguchi H. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86: 682-684, 2000.
477. Shindou H, Ishii S, Uozumi N, and Shimizu T. Roles of cytosolic phospholipase A (2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem Biophys Res Commun 271: 812-817, 2000.
478. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, and Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96: 6931-6936, 1999.
479. Silkworth JB, McLean B, and Stehbens WE. The effect of hypercholesterolemia on aortic endothelium studied en face. Atherosclerosis 22: 335-348, 1975.
480. Simpson RJ, Hammacher A, Smith DK, Matthews JM, and Ward LD. Interleukin-6: structure-function relationships. Protein Sci 6: 929-955, 1997.
481. Sisson SD and Dinarello CA. Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood 72: 1368-1374, 1988.
482. 2 synthesis. Arteriosclerosis 8: 359-367, 1988.
483. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, and Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 80: 1008-1014, 1998.
484. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, and Gamble JR. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 157: 360-368, 1996.
485. 2 for phosphatidic acid. Biochem J 321: 737-741, 1997.
486. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 19: 2841-2846, 1999.
487. Song L, Leung C, and Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest 108: 251-259, 2001.
488. Sramek A, Reiber JH, Gerrits WB, and Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 104: 762-767, 2001.
489. Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freeman J, Holmes G, Long R, Forbes A, and Kamm MA. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 349: 521-524, 1997.
490. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, Najib J, Maclouf J, and Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393: 790-793, 1998.
491. Stary HC, Blankenhorn DH, Chandler AB, Glagov S, Insull W Jr, Richardson M, Rosenfeld ME, Schaffer SA, Schwartz CJ, and Wagner WD. A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 85: 391-405, 1992.
492. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, and Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92: 1355-1374, 1995.
493. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, and Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89: 2462-2478, 1994.
494. Steel DJ, Tieman TL, Schwartz JH, and Feinmark SJ. Identification of an 8-lipoxygenase pathway in nervous tissue of Aplysia californica. J Biol Chem 272: 18673-18681, 1997.
495. Steinberg Lewis AD. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 95: 1062-1071, 1997.
496. Stengel D, Antonucci M, Gaoua W, Dachet C, Lesnik P, Hourton D, Ninio E, Chapman MJ, and Griglio S. Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. Arterioscler Thromb Vasc Biol 18: 1172-1180, 1998.
497. 4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes. Immunology 72: 206-212, 1991.
498. Stewart DJ. Impact of endothelin-1 on vascular structure and function. Am J Cardiol 82: 14S-16S, 1998.
499. Stopeck AT, Nicholson AC, Mancini FP, and Hajjar DP. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J Biol Chem 268: 17489-17494, 1993.
500. Stormorken H and Sakariassen KS. Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis. Thromb Res 88: 1-25, 1997.
501. Subbanagounder G, Leitinger N, Shih PT, Faull KF, and Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ Res 85: 311-318, 1999.
502. Sun D and Funk CD. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J Biol Chem 271: 24055-24062, 1996.
503. Sun X, Rozenfeld RA, Qu X, Huang W, Gonzalez-Crussi F, and Hsueh W. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol Gastrointest Liver Physiol 273: G56-G61, 1997.
504. Sun YP, Zhu BQ, Sievers RE, Isenberg WM, and Parmley WW. Aspirin inhibits platelet activity but does not attenuate experimental atherosclerosis. Am Heart J 125: 79-86, 1993.
505. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Honuchi S, Takahashi K, Kar Kruijt J, van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, and Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296, 1997.
506. Taga T, Narazaki M, Yasukawa K, Saito T, Miki D, Hamaguchi M, Davis S, Shoyab M, Yancopoulos GD, and Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 89: 10998-11001, 1992.
507. Takahara N, Kashiwagi A, Maegawa H, and Shigeta Y. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45: 559564, 1996.
508. 2 receptors. J Clin Invest 90: 136-141, 1992.
509. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185: 1693-1704, 1997.
510. Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, and Shapira L. Differentiation of monocytes to macrophages primes cells for lipopolysaccharide stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun 67: 5573-5578, 1999.
511. Takeya M, Yoshimura T, Leonard EJ, and Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 24: 534-539, 1993.
512. 5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes. Agents Actions 29: 324-327, 1990.
513. Tau G and Rothman P. Biologic functions of the IFN-gamma receptors. Allergy 54: 1233-1251, 1999.
514. Tedgui A and Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 88: 877-887, 2001.
515. Terkeltaub R, Banka CL, Solan J, Santoro D, Brand K, and Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 14: 47-53, 1994.
516. Tesfamariam B, Brown ML, and Cohen RA. 15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta. J Cardiovasc Pharmacol 25: 748-755, 1995.
517. Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, and Hoylaerts MF. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 99: 4486-4493, 2002.
518. Thivierge M, Alami N, Muller E, de Brum-Fernandes AJ, and Rola-Pleszczynski M. Transcriptional modulation of platelet-activating factor receptor gene expression by cyclic AMP. J Biol Chem 268: 17457-17462, 1993.
519. 2. J Clin Invest 102: 1994-2001, 1998.
520. 2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol 161: 3421-3430, 1998.
521. Tilg H, Trehu E, Atkins MB, Dinarello CA, and Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83: 113-118, 1994.
522. 2 gene family in mammals. J Biol Chem 272: 17247-17250, 1997.
523. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, and Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252, 1998.
524. Tracy RP. Epidemiological evidence for inflammation in cardiovascular disease. Thromb Haemost 82: 826-831, 1999.
525. Trigatti B, Rayburn H, Vinals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 96: 9322-9327, 1999.
526. Tsuji T, Nagata K, Koike J, Todoroki N, and Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol 56: 583-587, 1994.
527. Tuttle DL, Harrison JK, Anders C, Sleasman JW, and Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 72: 4962-4969, 1998.
528. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, and Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 25: 64-68, 1995.
529. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, and Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19: 932-938, 1999.
530. 2 in allergic response and parturition. Nature 390: 618-622, 1997.
531. Upston JM, Neuzil J, Witting PK, Alleva R, and Stocker R. Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, alpha-tocopherol-mediated peroxidation of cholesteryl esters. J Biol Chem 272: 30067-30074, 1997.
532. Vanderhoek JY, Bryant RW, and Bailey JM. Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J Biol Chem 255: 10064-10066, 1980.
533. Vanderhoek JY, Bryant RW, and Bailey JM. Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoids. Biochem Pharmacol 31: 3463-3467, 1982.
534. Van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR, ten Cate JW, and Aarden L. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179: 1253-1259, 1994.
535. Van Diest MJ, Herman AG, and Verbeuren TJ. Influence of hypercholesterolaemia on the reactivity of isolated rabbit arteries to 15-lipoxygenase metabolites of arachidonic acid: comparison with platelet-derived agents and vasodilators. Prostaglandins Leukotrienes Essent Fatty Acids 54: 135-145, 1996.
536. Van Kooten C, and Banchereau J. CD40-CD40 ligand. J Leukoc Biol 67: 2-17, 2000.
537. Vane JR, Bakhle YS, and Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
538. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W, and Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 22: 914-920, 2002.
539. Von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, and Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103: 1772-1777, 2001.
540. Waage A and Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63: 299-302, 1988.
541. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, and Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169: 333-338, 1989.
542. Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 6: 217-246, 1990.
543. Wahl SM, McCartney-Francis N, Allen JB, Dougherty EB, and Dougherty SF. Macrophage production of TGF-beta and regulation by TGF-beta. Ann NY Acad Sci 593: 188-196, 1990.
544. Wahli W, Braissant O, and Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol 2: 261-266, 1995.
545. Walker LN, Reidy MA, and Bowyer DE. Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am J Pathol 125: 450-459, 1986.
546. Wang N, Tabas I, Winchester R, Ravalli S, Rabbani LE, and Tall A. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem 271: 8837-8842, 1996.
547. Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, and Lysko PG. Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett 462: 145-150, 1999.
548. Watanabe T and Fan J. Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. Int J Cardiol 66 Suppl 1: S45-S55, 1998.
549. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, and Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96: 2882-2891, 1995.
550. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, and Berliner JA. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95: 774-782, 1995.
551. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, and Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 109: 1321-1330, 1989.
552. Weber KS, von Hundelshausen P, Clark-Lewis I, Weber PC, and Weber C. Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur J Immunol 29: 700-712, 1999.
553. Weijenberg MP, Feskens EJ, and Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 16: 499-503, 1996.
554. Wesley RB II, Meng X, Godin D, and Galis ZS. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol 18: 432-440, 1998.
555. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, and Zimmerman GA. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 97: 1525-1534, 1996.
556. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, and Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 95: 2297-2303, 1995.
557. Whitman SC, Ravisankar P, and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res 90: E34-E38, 2002.
558. Whitman SC, Ravisankar P, Elam H, and Daugherty A. Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice. Am J Pathol 157: 1819-1824, 2000.
559. Wilcox JN, Nelken NA, Coughlin SR, Gordon D, and Schall TJ. Local expression of inflammatory cytokines in human atherosclerotic plaques. J Atheroscler Thromb 1: S10-S13, 1994.
560. Williams CS and DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol Gastrointest Liver Physiol 270: G393-G400, 1996.
561. Williams KJ and Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15: 551-561, 1995.
562. Winsor GL, Waterhouse CC, MacLellan RL, and Stadnyk AW. Interleukin-4 and IFN-gamma differentially stimulate macrophage chemoattractant protein-1 (MCP-1) and eotaxin production by intestinal epithelial cells. J Interferon Cytokine Res 20: 299-308, 2000.
563. Wintergerst ES, Jelk J, and Asmis R. Differential expression of CD14, CD36 and the LDL receptor on human monocyte-derived macrophages. A novel cell culture system to study macrophage differentiation and heterogeneity. Histochem Cell Biol 110: 231-241, 1998.
564. Witztum JL and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991.
565. Wolbink GJ, Bossink AW, Groeneveld AB, de Groot MC, Thijs LG, and Hack CE. Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 177: 81-87, 1998.
566. Woods JW, Coffey MJ, Brock TG, Singer II, and Peters-Golden M. 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J Clin Invest 95: 2035-2046, 1995.
567. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, and Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341: 255-259, 1993.
568. Yamaguchi H, Haranaga S, Widen R, Friedman H, and Yamamoto Y. Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun 70: 2392-2398, 2002.
569. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Ohshiro H, Ishihara K, Matsuda T, Mori K, and Ogawa M. Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein-expression after ischemia/reperfusion in rat liver. Transplantation 68: 1459-1468, 1999.
570. Yamamoto S. "Enzymatic" lipid peroxidation: reactions of mammalian lipoxygenases. Free Radic Biol Med 10: 149-159, 1991.
571. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128: 117-131, 1992.
572. Yamamoto S, Suzuki H, and Ueda N. Arachidonate 12-lipoxygenases. Prog Lipid Res 36: 23-41, 1997.
573. Yang J, Furie BC, and Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 81: 1-7, 1999.
574. Yesner LM, Huh HY, Pearce SF, and Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16: 1019-1025, 1996.
575. 2 receptors in human platelets. J Pharmacol Exp Ther 270: 1192-1196, 1994.
576. Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T, and Yang YC. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol 151: 2555-2561, 1993.
577. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, and Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88: 5252-5256, 1991.
578. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, and Witztum JL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14: 32-40, 1994.
579. Yla-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sairkioja T, Witztum JL, and Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87: 1146-1152, 1991.
580. 4 that mediates chemotaxis. Nature 387: 620-624, 1997.
581. Young RA and Elliott TJ. Stress proteins, infection, and immune surveillance. Cell 59: 5-8, 1989.
582. Zeindler CM, Kratky RG, and Roach MR. Quantitative measurements of early atherosclerotic lesions on rabbit aortae from vascular casts. Atherosclerosis 76: 245-255, 1989.
583. Zibara K, Chignier E, Covacho C, Poston R, Canard G, Hardy P, and McGregor J. Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice. Arterioscler Thromb Vasc Biol 20: 2288-2296, 2000.
584. Zimmerman G. Inflammation: Basic Principles and Clinical Correlates (2nd ed.). New York: Raven, 1992, p. 149.
585. Zouki C, Beauchamp M, Baron C, and Filep JG. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 100: 522-529, 1997.
586. Zwaka TP, Hombach V, and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103: 1194-1197, 2001.